©The Author(s) 2025.
World J Gastroenterol. Sep 14, 2025; 31(34): 109825
Published online Sep 14, 2025. doi: 10.3748/wjg.v31.i34.109825
Published online Sep 14, 2025. doi: 10.3748/wjg.v31.i34.109825
Figure 6 In vivo effects of B-cell CLL/Lymphoma 10 on tumor growth and DLAT/p65 signaling.
A: Experimental timeline; B-G: Tumor volume (B, D, E) and weight (C, F, G) measurements. aP < 0.05; bP < 0.01; cP < 0.001; H: Hematoxylin and eosin staining and IHC for BCL10, DLAT, p65, and p-p65 (Ser536). Scale bars: 50 μm (main panels, 20 × magnification); 20 μm (insets, 40 × magnification).
- Citation: Xiao PT, Li CF, Liu YD, Zhong J, Cui XL, Liu C, Yang W. B cell CLL/lymphoma 10 promotes colorectal cancer cell proliferation and regulates cuproptosis sensitivity through the NF-κB signaling pathway. World J Gastroenterol 2025; 31(34): 109825
- URL: https://www.wjgnet.com/1007-9327/full/v31/i34/109825.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i34.109825